NCT05304936 2026-04-15
HCW9218 for Advanced Pancreatic Cancer
ImmunityBio, Inc.
Phase 1/2 Completed
Clinical Trials
4 trialsNCT05620732 2022-11-22
Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T
Shenzhen University General Hospital
Phase NA Recruiting
NCT05257122 2022-02-25
A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic Cancer
Fudan University
Phase 2 Unknown
NCT05143151 2021-12-03
CAR-T
Shenzhen University General Hospital
Phase 1/2 Unknown